Record Details

<div><p>Recent Pharmaceutical Patent Decisions in the United States</p></div>

Online Publishing @ NISCAIR

View Archive Info
 
 
Field Value
 
Authentication Code dc
 
Title Statement <div><p>Recent Pharmaceutical Patent Decisions in the United States</p></div>
 
Added Entry - Uncontrolled Name Baltatzis, Andreas ; Kramer Amado P.C.
Marvin, Shoshana
 
Uncontrolled Index Term Pharmaceutical patents; patent law; United States patent law
 
Summary, etc. <p><span>There has been a renewed interest of the Supreme Court of the United States in patent law, particularly with regard to pharma related patents. The overall trend in US patent law is the continued tension between the Court of Appeals for the Federal Circuit (the Federal Circuit), the patent specialty court in the United States which favours broad patent rights, and the Supreme Court of the United States, which uses its supervisory authority to reign in the strong patent rights advocated by the lower court. In this paper, recent important decisions with regard to pharmaceutical patents that highlight the Supreme Court’s oversight of the Federal Circuit’s patent decisions are reviewed. A survey of recent decisions that exemplify the Federal Circuit’s broad view of patent rights, by expanding patent-holders’ rights whether affirming or reversing District Court decisions that found patents invalid or unenforceable is also covered in the paper. These decisions may face appeal at the Supreme Court and result in similar reversal.</span></p>
 
Publication, Distribution, Etc. Journal of Intellectual Property Rights (JIPR)
2023-04-03 15:56:55
 
Electronic Location and Access application/pdf
http://op.niscair.res.in/index.php/JIPR/article/view/3293
 
Data Source Entry Journal of Intellectual Property Rights (JIPR); ##issue.vol## 19, ##issue.no## 1 (2014): Journal of Intellectual Property Rights
 
Language Note en
 
Nonspecific Relationship Entry http://op.niscair.res.in/index.php/JIPR/article/download/3293/8562